Iwakaze Capital, Inc.

About The Fund

Iwakaze Capital, Inc., operating under the brand name Curie Capital, is a venture capital firm based in Amsterdam, the Netherlands, with a focus on empowering investments for a sustainable future. Specializing in equity investments, Curie Capital has built its expertise in seeding innovative startups and supporting early-stage ventures, particularly targeting the Life Sciences sector. With an investment thesis that combines an appetite for risk and a commitment to supporting groundbreaking medical products, the firm has become a go-to source for talented teams in need of funding for their Biotechnology, Pharmaceutical, and Medical Technology ventures, especially those concentrating on therapeutics, diagnostics, or class IIb and III medical devices. Curie Capital exercises thorough selectivity, choosing to invest in companies that hold a Dutch headquarters and are compliant with the RVO seed capital regulations, typically those that have not exceeded 3.5 million euros in equity or convertible loan agreements to date. The firm works in concert with experienced co-investors and leverages a broad network to bolster its portfolio companies beyond the mere provision of capital, directly assisting in the company-building process. As of the latest information given, Curie Capital is managing its Curie Capital 3 fund and anticipates launching Curie Capital 4 in 2025, which aims to broaden the scope of investment opportunities to high-impact Life Sciences companies within Europe. The firm's portfolio aligns with their strategic approach, favoring transactions that capitalize on operational and management expertise. Their team is composed of life science experts and business analysts, including notable partners and associates who guide life science companies through their research and development cycles. The firm's website provides insights not just into their investment strategy and portfolio but also keeps interested parties informed on news relevant to their investments and the broader Life Science community.